As shown in Table 1, compared with included patients, those excluded patients had significantly lower ALT level (147.38±30.15 vs 183.56±51.02, p = 0.03) but higher ratio of hepatic steatosis (46.3% vs 30.6%, p = 0.04). This evidence concerns the gene GPT and Hepatic steatosis.